Exelixis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. 

CEO
Michael M. Morrissey
CEOMichael M. Morrissey
Employees
1,077
Employees1,077
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
1994
Founded1994
Employees
1,077
Employees1,077

EXEL Key Statistics

Market cap
14.62B
Market cap14.62B
Price-Earnings ratio
18.36
Price-Earnings ratio18.36
Dividend yield
—
Dividend yield—
Average volume
2.16M
Average volume2.16M
High today
$59.50
High today$59.50
Low today
$59.50
Low today$59.50
Open price
$58.07
Open price$58.07
Volume
5.22K
Volume5.22K
52 Week high
$61.14
52 Week high$61.14
52 Week low
$33.76
52 Week low$33.76

Stock Snapshot

Exelixis(EXEL) stock is priced at $59.50, giving the company a market capitalization of 14.62B. It carries a P/E multiple of 18.36.

On 2026-10-09, Exelixis(EXEL) stock moved within a range of $59.50 to $59.50. With shares now at $59.50, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading volume for Exelixis(EXEL) stock has reached 5.22K, versus its average volume of 2.16M.

The stock's 52-week range extends from a low of $33.76 to a high of $61.14.

The stock's 52-week range extends from a low of $33.76 to a high of $61.14.

EXEL News

TipRanks 1d
Exelixis price target lowered to $45 from $46 at RBC Capital

RBC Capital lowered the firm’s price target on Exelixis (EXEL) to $45 from $46 and keeps a Sector Perform rating on the shares as part of a broader research not...

Zacks 1d
Here's Why Exelixis is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different wa...

Here's Why Exelixis is a Strong Value Stock
Simply Wall St 4d
Exelixis, Inc. - Simply Wall Street

...

Exelixis, Inc. - Simply Wall Street

Analyst ratings

58%

of 19 ratings
Buy
31.6%
Hold
57.9%
Sell
10.5%

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.